Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase
about
sameAs
Genome-wide analyses of borderline personality featuresExpression and localization of myosin-1d in the developing nervous systemMetabolic acetate therapy improves phenotype in the tremor rat model of Canavan diseaseIn Vivo Detection of Perinatal Brain Metabolite Changes in a Rabbit Model of Intrauterine Growth Restriction (IUGR)Structure of aspartoacylase, the brain enzyme impaired in Canavan diseaseMutational analysis of aspartoacylase: implications for Canavan diseaseLocalisation of N-acetylaspartate in oligodendrocytes/myelinN-Acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylationMetabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophreniaMolecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartiaNur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNSLongitudinal 1H MRS of rat forebrain from infancy to adulthood reveals adolescence as a distinctive phase of neurometabolite development.Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders.In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders.N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.Myelin lipid abnormalities in the aspartoacylase-deficient tremor rat.Increasing N-acetylaspartate in the Brain during Postnatal Myelination Does Not Cause the CNS Pathologies of Canavan Disease.Whole-brain proton MR spectroscopic imaging of mild-to-moderate traumatic brain injury and correlation with neuropsychological deficitsDefective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease.A metabolomic comparison of mouse models of the Neuronal Ceroid Lipofuscinoses.Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study.Elevated CSF N-acetylaspartylglutamate suggests specific molecular diagnostic abnormalities in patients with white matter diseases.The energetics of CNS white matter.Long-term follow-up after gene therapy for canavan disease.Modification of aspartoacylase for potential use in enzyme replacement therapy for the treatment of Canavan diseaseLipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models.Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized miceMyelin associated glycoprotein cross-linking triggers its partitioning into lipid rafts, specific signaling events and cytoskeletal rearrangements in oligodendrocytes.1H-Nuclear magnetic resonance-based metabolomic analysis of brain in mice with nicotine treatment.Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis.Extensive aspartoacylase expression in the rat central nervous system.MRSI correlates of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.Transcriptional regulation of N-acetylaspartate metabolism in the 5xFAD model of Alzheimer's disease: evidence for neuron-glia communication during energetic crisis.Intravenous ethanol infusion decreases human cortical γ-aminobutyric acid and N-acetylaspartate as measured with proton magnetic resonance spectroscopy at 4 tesla.Alterations in frontal white matter neurochemistry and microstructure in schizophrenia: implications for neuroinflammationGestational and lactational iron deficiency alters the developing striatal metabolome and associated behaviors in young rats.Making the White Matter Matters: Progress in Understanding Canavan's Disease and Therapeutic Interventions Through Eight Decades.Serum levels of N-acetyl-aspartate in migraine and tension-type headache.
P2860
Q22251101-CBD01675-3698-49BF-88ED-8F1DA9C2DDDEQ24303720-2605CBFC-E8F3-47E4-A6E5-D902F777BB3CQ24605407-CF1A2B77-C1B7-43E0-8110-2840F5E7395EQ27303663-E3A624BA-41C1-4390-B3DB-4C2786FF4F99Q27640995-F49BBD5A-698F-4A6B-98A0-597C459A72B6Q28295349-98F35F2A-8822-47D2-98D0-18FFF2982A07Q28304873-DD238F38-280B-4365-84D9-8BDCF3155B29Q28305798-089BB0C3-F743-4FBE-BA39-159716CB50B2Q28469040-2977C261-ECED-4400-A33D-0BD7AC0080B6Q28588930-A46AA00D-5B8A-423F-AD41-197217E9C588Q30485283-E275BBBE-093C-4001-8D71-F9D38DBAEAE4Q30586192-BC65F05A-4151-443E-8247-B65AC693DEC4Q30593705-8D7620BC-49C0-437D-AF1D-E02834790D12Q30698264-063D11C5-22B5-4447-B468-AB2BD9D42765Q31132463-43DBC348-EA2B-419E-A68C-B5FADA1EA351Q32115381-EC630285-DCD9-4AD3-B1E4-53A09AE74E6EQ33271816-10387650-12E5-40FB-AD8B-81BC8AA00CB5Q33334499-DA4B8E8A-22E7-45CC-9541-3573941B3937Q33753200-C0579578-A31B-4E76-A993-F9F44319C9C1Q33841629-6E6298D6-7E55-4F33-9C80-0BB5FE67FB6DQ33933163-D1FFCC11-3E9F-45E3-B787-41CA714EB653Q34007930-5783E9FC-A726-434E-8BE1-4B19861486C3Q34066948-886F88E0-951D-4461-8C13-8D14B3B0C598Q34143204-79805FDD-BBFB-459B-91AE-BAC2C22AF594Q34244625-747A3F93-D740-48E4-9E8F-5EF1FD124F0EQ34318553-A994F93D-FC78-418D-858C-DD7F38DADD4DQ34500635-0B6F1852-F78D-4D50-AF4E-839331D2212DQ34560712-3D7738E6-71F2-4A6C-84E8-62A915308452Q34979163-4F47F27C-B840-4283-B9F8-D2118EA6A752Q35040508-9361347B-2C6B-4F2A-A2C5-9FECCD6103B8Q35099951-A8A0A744-E6B3-43DE-8469-E846B20FF2E2Q35110705-61EBB3E3-60E2-495E-BAA4-3F154C2AF372Q35126855-B6057122-64D9-48C2-A754-FC7993803D1DQ35130440-EE594236-84B6-477C-B761-85DA4698697BQ35371270-F263B18D-129D-4206-B364-0E6E4F569364Q35583217-B9518163-56E7-4889-AB8E-C5195298EF5DQ35715200-3DE8D193-76BB-40B1-995F-5F148EF96D04Q35842661-837B5116-294E-4D5A-8C92-8CF461859A10Q35848706-0A1C1000-7152-4CAC-98B1-5E00A8232C81Q36052148-83076007-A7AD-44DD-B6DE-D0C09846FB0A
P2860
Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase
description
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
scientific article (publication date: August 2001)
@en
vedecký článok (publikovaný 2001-08)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd in 2001-08)
@nl
наукова стаття, опублікована в серпні 2001
@uk
مقالة علمية (نشرت في أغسطس 2001)
@ar
name
Intraneuronal N-acetylaspartat ...... elin-associated aspartoacylase
@ast
Intraneuronal N-acetylaspartat ...... elin-associated aspartoacylase
@en
Intraneuronal N-acetylaspartat ...... elin-associated aspartoacylase
@nl
type
label
Intraneuronal N-acetylaspartat ...... elin-associated aspartoacylase
@ast
Intraneuronal N-acetylaspartat ...... elin-associated aspartoacylase
@en
Intraneuronal N-acetylaspartat ...... elin-associated aspartoacylase
@nl
prefLabel
Intraneuronal N-acetylaspartat ...... elin-associated aspartoacylase
@ast
Intraneuronal N-acetylaspartat ...... elin-associated aspartoacylase
@en
Intraneuronal N-acetylaspartat ...... elin-associated aspartoacylase
@nl
P2093
P3181
P1476
Intraneuronal N-acetylaspartat ...... elin-associated aspartoacylase
@en
P2093
P304
P3181
P356
10.1046/J.1471-4159.2001.00456.X
P407
P577
2001-08-01T00:00:00Z